T-Cell Therapy: How to Model a Trispecific T-cell Engager For MM: Lessons from ISB

Time: 12:55 pm
day: Day Two


  • Discussing the efficacy, safety of T-cell engagers
  • Assessing the benefits and restrictions of collecting data in vivo vs in vitro for a T-cell engager
  • Overviewing the translational relevance of various datasets